In lymphoma, the lymphocytes multiply and congregate in the lymph nodes and other tissues. This abnormal distribution of lymphocytes confuses the immune system, making it less effective against invading pathogens. Like most people who are diagnosed with this form of cancer, Bongino felt fine at the time of diagnosis.
The misery and fight is a consequence of chemotherapy, not mere cancer
Bongino is not merely fighting cancer. The pain and misery that patients ultimately face is caused by the chemotherapy “treatments.” Dan Bongino, a great American patriot and courageous fighter for our constitutional republic, has used his position of influence to project strength and hope during his hospital stays, but despite how passionate and strong Bongino is on the surface, he cannot escape the laws of cause and effect.
Chemotherapy agents are not treatments; they are poisons that cause mitochondrial dysfunction. Their immediate effects include hair loss, appetite loss, nausea, vomiting, diarrhea and mouth sores. As the poisons infiltrate the blood of the patient, the patient’s white blood cell count diminishes, increasing the patient’s risk of infection, complications from infection, and death. How many covid-19 deaths were the direct result of impaired immune systems, destroyed by chemotherapy?
In addition to these issues, chemotherapy also causes risk of internal bleeding and bruising because the patient's blood platelets are destroyed by the poison. Chemotherapy patients also suffer from severe fatigue because their red blood cells are destroyed by the poison. The chemotherapy wastes away the body's last vestige of defense, turning the body into a dilapidated battlefield, a helpless terrain.
Chemotherapy causes mitochondrial dysfunction, initiating diseased processes throughout the body
A study published in the American Journal of Physiology-Cell Physiology lambastes the chemotherapy agents - doxorubicin and paclitaxel -- because these poisons cause mitochondrial dysfunction in the muscles of patients. Mitochondria are the powerhouses of cells, instrumental in producing the ATP energy that is essential for cancer recovery! Doxorubicin is one of the main ingredients used in the most common type of chemotherapy regime for the “treatment” of Hodgkin’s lymphoma. This poisonous regime includes adriamycin (doxorubicin), bleomycin, vinblastine and dacarbazine (DTIC).
Doxorubicin is notorious for damaging the heart. Bleomycin is known for damaging the lungs. Many chemotherapy drugs cause infertility, and some increase the risk of secondary cancers, especially leukemia. Dan Bongino is a patriot and a fighter, just like Rush Limbaugh, but no matter how hard they fight for their country and their values, they are sadly choosing to succumb to the most lethal, cancer-causing chemicals used in modern medicine. Dan Bongino and Rush Limbaugh are not merely fighting cancer. Their bodies are fighting toxic poisons administered by the American medical system. It doesn't matter how much Bongino and Limbaugh praise their oncologists, their fight for survival is overshadowed by a toxic cocktail that rapidly ages their body and destroys their quality of life. Their fight for survival is made even harder as they suffer through poisonous treatments that deplete their body’s ability to heal in the short and long term.
Under the spell of chemotherapy, patients fight in vain, as their healthy cells and ATP energy production are damaged right along with the cancerous cells. This destruction of the inner terrain forever curses their body’s ability to heal. This is why “cancer survivors” often return to the hospital with more debilitating chronic health issues, opportunistic infections and secondary cancers. The chemotherapy prolongs their suffering, not their life.
We pray for Dan Bongino and hope that he learns the truth about toxic chemotherapy and acts now to preserve his health before it is further destroyed by the cancer industrial complex.
For more on this sensitive issue, research at Cancer.news.
Sources include:
Please contact us for more information.
